Position in ATAI
as of Jun 30, 2026
· filed Aug 26, 2026
Position Value
$10,540
+$3,460 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#199
of 239 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Principia Wealth Advisory, LLC holds $14,097,964 across 26 Biotechnology names. ATAI ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EYPT |
EyePoint, Inc.
|
649,944 | $9,294,199 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
440,618 | $4,326,868 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
6,478 | $252,706 | |
| 4 | INCY |
Incyte Corp
|
1,524 | $172,760 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29 | $14,405 | |
| 6 | ATAI |
AtaiBeckley Inc.
This page
|
2,000 | $10,540 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | RPRX |
Royalty Pharma plc
|
57 | $3,195 |
All Filings in ATAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,540 | 2,000 | Shares | Sole | 2026-08-26 | |
| 2026-03-31 | $7,080 | 2,000 | Shares | Sole | 2026-08-26 | |
| 2025-12-31 | $8,180 | 2,000 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||